Has Kris Gaston, MD received payments from drug or device companies?

Yes. Drug and device makers reported $31,760 in general payments to Kris Gaston, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kris Gaston, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kris Gaston, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kris Gaston, MD

Urology · Charlotte, NCNPI 1881657252

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,119 of the $31,760 with a category attached, or 72.8%. 30 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 38.6% of the total. 2025 is the largest year on record at $28,111, more than ten times the $229 reported in 2019. Among urology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,760in general payments, 2019–2025

Across 78 payments — averaging $407.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Scientific Affairs, LLC$12K
Johnson & Johnson$12K
Avyxa Pharma, LLC$4K
Urogen Pharma, Inc.$482
Dendreon Pharmaceuticals LLC$451
Biom'up France SAS$360
plus $2K from 24 others

What the payments were for

Consulting fees$23,11973%
Speaking & faculty fees$2,0006%
Travel & lodging$1,5805%
Food & beverage$5,06116%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Scientific Affairs, LLC	3	$12,267
Johnson & Johnson(2 entities)	26	$11,948
Avyxa Pharma, LLC	5	$3,847
Urogen Pharma, Inc.	4	$482
Dendreon Pharmaceuticals LLC	2	$451
Biom'up France SAS	3	$360
Intuitive Surgical	1	$201
Medtronic	2	$195
Dilon Technologies, Inc.	2	$179
Novartis	1	$161
Immunitybio, Inc.	1	$150
Angiodynamics, Inc.	1	$143
Kerecis Limited	2	$136
Bayer	1	$131
Astellas Pharma US Inc	1	$129
Foundation Medicine, Inc.	2	$127
AstraZeneca	1	$107
Astellas Pharma Global Development	1	$104
Blue Earth Diagnostics	1	$100
Pfizer	5	$96
EMD Serono, Inc.	1	$95
Boston Scientific	1	$85
Bioprotect Medical, Inc.	1	$67
Olympus America Inc.	2	$51
Convatec Inc.	2	$38
Coloplast	2	$31
Ferring Pharmaceuticals Inc.	1	$26
Innovation Technologies Inc	1	$25
180 Medical, Inc.	1	$16
Davol Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,760 in reported general payments places this provider in the 90th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$143,920

Medicare patients

337

Services billed

3,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GemtesaVibegron	19	$8,859
Solifenacin Succinate	28	$1,245
Finasteride	40	$552
Tamsulosin Hcl	39	$384
Ciprofloxacin Hcl	32	$144
Cephalexin	13	$127
Oxybutynin Chloride	15	$98
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	14	$88
Methocarbamol	15	$76
Acetaminophen-CodeineAcetaminophen With Codeine	12	$57
Levofloxacin	38	$47
Tramadol Hcl	28	$40
Diazepam	16	$14

Paid to pharmacies, not to this prescriber.

Other urology in Charlotte

Michael KennellyCharlotte$1.3M
Manish PatelCharlotte$84K
Todd CohenCharlotte$18K
Ornob RoyCharlotte$17K
Maxim McKibbenCharlotte$15K
Robert LippittSmithfield$11.4M
John KasparRaleigh$1.1M
Judd MoulDurham$1M
Daniel GeorgeDurham$1M
Scott MacdiarmidGreensboro$774K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →